3rd Quarter - Report

CHAMBER HILL STRATEGIES for MAYO COLLABORATIVE SERVICES, INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Issues impacting diagnostics including FDA regulation of laboratory developed tests; H.R.2369, the VALID Act of 2023; S. 1000/H.R. 2377, the Saving Access to Laboratory Services Act

LobbyistCovered position, as disclosed
STACEY RAMPY Legislative Director, Rep. Anna Eshoo (CA-15); Legislative Assistant, Sen. Robert Torricelli (D-NJ); Legislative Assistant, Sen. Barbara Boxer (D-CA)

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1000 (118th), H.R. 2369 (118th), H.R. 2377 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.